Identification and Characterization of Novel Therapeutics for the Treatment and Prevention of Epilepsy and Neuroprotectants as Counter Measures (CM) to Chemical Threats

The National Institute of Neurological Disorders and Stroke (NINDS) intends to negotiate on a non-competitive basis the continuation of a contract with the University of Utah for the "Identification and Characterization of novel Therapeutics for the